UTI insider buying and SEC filings, explained
Universal Technical Institute Inc. · CIK 1261654
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$31.1M
Insiders who bought
2
Sold (not marked 10b5-1)
$136.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 28, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 1,000 shares at about $19.68 ($20K), reported as a purchase (code P). Holdings up 1% to 153,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 30, 2026 |
| Sep 21, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 1,000 shares at about $19.83 ($20K), reported as a purchase (code P). Holdings up 1% to 152,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 23, 2026 |
| Aug 27, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 1,000 shares at about $21.80 ($22K), reported as a purchase (code P). Holdings up 1% to 151,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 25, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 1,000 shares at about $21.77 ($22K), reported as a purchase (code P). Holdings up 1% to 150,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| Aug 12, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 1,000 shares at about $25.95 ($26K), reported as a purchase (code P). Holdings up 1% to 149,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Aug 10, 2026 | Purchase (code P) | Robert Thomas Devincenzi (Director) bought 8,000 shares at about $28.21 ($226K), reported as a purchase (code P). Holdings up 6% to 148,330 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 12, 2026 |
| Jun 29, 2026 | Sale | Jerome Alan Grant (CEO and Director) sold 94,500 shares at about $41.40 ($3.9M). Holdings down 22% to 335,715 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 30, 2026 |
| Jun 22, 2026 | Sale | Kevin Prehn (President / COO) sold 4,545 shares at $40.00 ($182K). Holdings down 14% to 27,025 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 24, 2026 |
| Jun 8, 2026 | Sale | Christopher S Shackelton (Director) sold 3,000,000 shares indirectly at $41.40 ($124.2M). Indirect holdings down 76% to 971,440 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Jun 10, 2026 |
| Jun 5, 2026 | Sale | Christine Kline (Senior Vice President and CAO) sold 3,500 shares at about $44.42 ($155K). Holdings down 8% to 43,006 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 8, 2026 |
| May 11, 2026 | Sale | Linda J. Srere (Director) sold 15,000 shares at about $36.59 ($549K). Holdings down 11% to 127,564 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 13, 2026 |
| Mar 27, 2026 | Sale | Christopher E. Kevane (EVP and Chief Legal Officer) sold 23,654 shares at about $37.55 ($888K). Holdings down 22% to 83,521 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 31, 2026 |
| Mar 17, 2026 | Sale | George W. Brochick (Director) sold 5,000 shares indirectly (by trust) at about $36.59 ($183K). Holdings by trust down 15% to 27,516 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Mar 6, 2026 | Sale | Shannon Lei Okinaka (Director) sold 10,000 shares at about $34.74 ($347K). Holdings down 34% to 19,808 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 4, 2026 | Sale | Todd A Hitchcock (President / COO) sold 16,500 shares at $37.33 ($616K). Holdings down 14% to 104,084 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 6, 2026 |
| May 12, 2025 | Sale | Sherrell Smith (EVP, Chief Academic Officer) sold 50,000 shares indirectly (by spouse) at about $33.84 ($1.7M). Holdings by spouse down 55% to 41,219 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 6, 2026 |
| Mar 2, 2026 | Sale | Sherrell Smith (EVP, Chief Academic Officer) sold 52,671 shares directly and indirectly (by spouse) at about $37.04 ($2.0M). Direct holdings down 19% to 129,375 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Feb 27, 2026 | Sale | Jerome Alan Grant (CEO and Director) sold 60,040 shares at about $34.95 ($2.1M). Holdings down 12% to 430,215 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 2, 2026 |
| Feb 13, 2026 | Sale | Carolyn Ann Frank (SVP/Chief HR Officer) sold 1,750 shares at $30.08 ($53K). Holdings down 5% to 30,272 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Dec 3–5, 2025 | Purchase (code P) | Christopher S Shackelton (Director) bought 547,066 shares in 2 share classes indirectly between Dec 3, 2025 and Dec 5, 2025 at about $25.01 ($13.7M), reported as a purchase (code P). Indirect holdings of Common Stock up 11% to 3,971,440 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Dec 5, 2025 |
| Dec 1–2, 2025 | Purchase (code P) | Christopher S Shackelton (Director) bought 708,107 shares in 2 share classes indirectly between Dec 1, 2025 and Dec 2, 2025 at about $24.19 ($17.1M), reported as a purchase (code P). Indirect holdings of Common Stock up 19% to 3,424,374 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Dec 3, 2025 |
37 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow UTI in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.